SNX29 and ovarian serous cystadenocarcinoma: In the OS analysis, Cox regression analysis revealed that high SNX29 expression was a protective factor for BLCA (p = 0.007), STAD (p = 0.014), ovarian serous cystadenocarcinoma (OV) (p = 0.009), and LIHC (p = 0.031).